HPLC column NUCLEODUR ® C 8 Gravity, 3 µm, 100 mm, 4.6 mm
Order number: 342P.1
Part number: AC100007305
£ 851.40*
*Prices plus VAT plus shipping costs£ 1021.68*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Engineered to maintain reliability in process-driven workflows, the HPLC column NUCLEODUR ® C 8 Gravity, featuring a 3 μm particle size and a 100 mm x 4.6 mm column shape, delivers exceptional performance for the separation of basic and ionizable analytes. Its high density C 8 phase, based on high purity NUCLEODUR ® silica gel, boasts an endcapping that suppresses unwanted polar interactions, making it ideal for RP applications. With a pH stability range of 1.0-11.0, this column offers superior base deactivation and LC/MS suitability, making it a valuable asset for method development. The column's specific surface area of 340 m²/g ensures efficient separations, while its temperature stability up to 60°C allows for versatile usage
- Category: Separation columns for HPLC
- Pore volume: 0.9 ml/g
- Specific surface according to BET: 340 m²/g
- USP listing: L7
- Phase: C 8 Gravity
- L x Ø internal (column): 100 x 4.6 mm
- Column volume: 1.65 ml
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Column shape: Analytical separation column
- Pressure stability: 600 bar
- Eluent in column: Acetonitrile - Water
- Particle size: 3 µm
- Temperature stability: 60 ° C
- Pore size: 110 Å
- Surface chemistry: Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification
- Particle type: Fully porous particles (FPP)
- Similar phases: NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8
- Endcapped: yes
- pH stability: 1,0-11,0
- Separation principle: Reversed phase (RP)
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
- Column type: HPLC column
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 1.65 ml |
| Particle size | : | 3 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 100 x 4.6 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
